Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07104396 · ClinicalTrials.gov registry record
Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics
A clinical trial of Substance Use Disorders (SUDs), sponsored by Square2 Systems.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07104396: Recruiting study of Substance Use Disorders (SUDs), sponsored by Square2 Systems.
NCT07104396 is a study of Substance Use Disorders (SUDs) that is actively recruiting participants, run by Square2 Systems. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07104396, a study of Substance Use Disorders (SUDs), is actively recruiting participants, sponsored by Square2 Systems.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Primary Outcome
Each participant will be asked to complete the standardized 10-item System Usability Scale (SUS) to evaluate the usability of Cogito (e.g., "I think I would like to use this system frequently"), ranging from "strongly agree" to "strongly disagree".
Conditions Studied
Interventions
- OTHER Cogito digital therapeutics development platform
Study Locations (1)
New Hampshire
- Square 2 Systems - Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-02 |
| Est. Completion | 2025-08-31 |
What NCT07104396 shows while recruiting
NCT07104396 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Substance Use Disorders (SUDs) appearing as the primary indexed condition, and to 1 intervention - of which Cogito digital therapeutics development platform is the first listed.
NCT07104396 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT07104396 about?
NCT07104396 is a clinical study titled "Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics". This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with...
What is the current status of trial NCT07104396?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-07-02. Estimated completion is 2025-08-31.
What conditions does trial NCT07104396 study?
This clinical trial studies the following conditions: Substance Use Disorders (SUDs).
What interventions are being tested in trial NCT07104396?
The interventions under investigation include: Cogito digital therapeutics development platform (OTHER).
Who is sponsoring clinical trial NCT07104396?
This trial is sponsored by Square2 Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07104396 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI